Hikma Ventures

O7 Therapy is revolutionizing access to mental health services through a digital platform and mobile app offering online therapy, psycho-educational resources, and corporate wellness programs, to empower Arabic-speaking people to pursue their mental wellness journey. We use cutting edge AI in a very engaging user experience producing an effective therapeutic journey. Additionally, we provide Employee Wellness Programs for organizations through a unique B2B2E model, prioritizing the impact of mental health challenges in the workplace, and focusing on raising awareness and understanding, reducing stigma and shame, creating safe and supportive spaces, and implementing strategies that promote mental wellbeing.

Altoida AG, founded in 2016 and based in Lucerne, Switzerland, develops a healthcare platform and application specifically for Alzheimer’s patients. The Altoida application is the first validated solution designed to predict the risk of Alzheimer’s disease before symptoms appear, providing healthcare professionals with objective measurements of cognitive performance. The platform utilizes an augmented reality framework to conduct various tests that assess spatial memory, prospective memory, and executive functions. These tests can identify early and subtle cognitive changes up to six years prior to the onset of typical neurodegenerative symptoms. The Altoida Neuro Motor Index (NMI) serves as an active digital biomarker for early detection of cognitive and functional changes. The application is intended for patients aged 62 and older and is used as an adjunctive tool to evaluate perceptual and memory function. Results from the tests are accessible in real-time via a secure web-based dashboard, ensuring compliance with HIPAA regulations. Altoida's innovative approach aims to make brain health assessments more affordable, accessible, and actionable for doctors, researchers, and healthcare providers.

Altibbi Ltd. operates a digital health platform catering to users and healthcare professionals in the Middle East. Founded in 2008 and based in Dubai, the platform provides comprehensive health information on various medical topics, including chronic conditions, dental health, and skin diseases. It offers a range of resources, such as a medical dictionary, articles, videos, and an encyclopedia of medicines, along with a question-and-answer feature. Altibbi also allows users to access health advice 24/7 through its website and mobile applications. Additionally, the platform facilitates the booking of video consultations with a selected group of doctors and provides translations of medical terminology into Arabic, enhancing patients' healthcare knowledge and access to professional assistance.

Activ Surgical Inc. is a Boston-based company focused on developing innovative solutions for robotic surgery. Founded in 2014, the company has created a robotic surgery platform that leverages advanced computer vision, artificial intelligence, and robotics to assist surgeons during complex procedures. Its flagship product, the Smart Tissue Autonomous Robot (STAR), aims to improve surgical outcomes by enhancing intraoperative decision-making and reducing the risk of unintended surgical errors. By utilizing a patent-protected surgical software platform, Activ Surgical strives to transform surgical vision and enable safer, more efficient surgeries through the integration of augmented reality and AI-driven technologies.

NuvoAir AB develops Air Next home spirometer, a medical device to monitor lung function. It offers its products online. The company was founded in 2015 and is based in Stockholm, Sweden.

BioSapien is a biotech startup that focuses on developing a 3D printed drug delivery platform to provide FDA approved drugs. The startup's device allows chemotherapy to be delivered intravenously through a controlled drug release and enables physicians to reduce harmful side-effects and dramatically reduce costs. BioSapien was established in 2018 and is based in New York.

Biolinq Inc. is a San Diego-based company that specializes in developing skin-applied electronic sensors designed to analyze body fluids for health monitoring. Founded in 2012 and originally known as Electrozyme LLC, Biolinq aims to enhance the experience of individuals with diabetes by providing a more affordable and pain-free alternative to conventional continuous glucose monitoring (CGM) systems. The company's platform features minimally invasive electrochemical biosensors capable of measuring multiple analytes, including glucose, ketones, and lactate. This innovative technology not only facilitates easier blood glucose monitoring but also delivers actionable insights into metabolic health, significantly improving the quality of life for patients managing diabetes.

Click Therapeutics, Inc. specializes in the engineering, validation, development, and commercialization of digital therapeutic solutions aimed at addressing unmet medical needs through cognitive and neurobehavioral modification. Founded in 2012 and based in New York, the company offers innovative digital therapeutics for a range of conditions, including smoking cessation, major depressive disorder, schizophrenia, insomnia, and chronic pain. Its Digital Therapeutics™ are designed to function independently or alongside traditional biomedical treatments, utilizing the Clickometrics® adaptive data science platform to personalize user experiences and enhance engagement. Notably, Click's smoking cessation program has gained widespread access through various payers and providers, while its primary prescription program is advancing into a significant phase III clinical trial for major depressive disorder in adults.

SeamlessMD is a digital patient engagement platform focused on improving surgical outcomes and enhancing the patient experience. The company partners with healthcare providers to implement and optimize enhanced recovery protocols after surgery, utilizing design, data, and technology. Its platform enables hospitals to engage in remote patient monitoring and gather critical data, which helps in improving surgical results and minimizing readmissions. By streamlining the patient journey and providing comprehensive support, SeamlessMD aims to deliver quality surgical care while reducing costs for healthcare providers.

Lemonaid Health focuses on changing the patient experience and improving and optimizing clinical care through the advancements in machine learning and AI. It leverages evidence-based guidelines and the most up-to-date clinical protocols to offer a service direct to consumers for less than typical co-pays. It was founded in 2013 and is headquartered in San Francisco, California.

Altoida AG, founded in 2016 and based in Lucerne, Switzerland, develops a healthcare platform and application specifically for Alzheimer’s patients. The Altoida application is the first validated solution designed to predict the risk of Alzheimer’s disease before symptoms appear, providing healthcare professionals with objective measurements of cognitive performance. The platform utilizes an augmented reality framework to conduct various tests that assess spatial memory, prospective memory, and executive functions. These tests can identify early and subtle cognitive changes up to six years prior to the onset of typical neurodegenerative symptoms. The Altoida Neuro Motor Index (NMI) serves as an active digital biomarker for early detection of cognitive and functional changes. The application is intended for patients aged 62 and older and is used as an adjunctive tool to evaluate perceptual and memory function. Results from the tests are accessible in real-time via a secure web-based dashboard, ensuring compliance with HIPAA regulations. Altoida's innovative approach aims to make brain health assessments more affordable, accessible, and actionable for doctors, researchers, and healthcare providers.

Winterlight Labs Inc. develops a speech-based platform for detecting cognitive and mental diseases such as, dementia and Alzheimer’s disease. Its AI (artificial intelligence) diagnostic platform assesses and monitors cognitive health by quantifying speech and language patterns. The company's platform has applications in clinical trials, long-term and primary care, and speech-language pathology. Winterlight Labs Inc. was founded in 2015 and is based in Toronto, Canada.

Pillo, Inc. designs and develops a digital care management platform that provides health care plans for adults with chronic conditions at home. The company offers Pillo, a robot, which enable people to manage their health; answer health and wellness questions; connect with healthcare professionals; manage vitamins and medication; and store, dispense, and order refills when required. The company’s robot also sends notifications to the user when medications are missed; sees and hears user to keep them healthy and safe; and syncs with wearables and smart home devices. Pillo, Inc. was incorporated in 2015 and is based in New York, New York.

Nebula Genomics, founded in 2016 and based in San Francisco, California, is a company focused on human genome sequencing and health data. It aims to create a comprehensive and trusted marketplace for genomic and health data, facilitating access for consumers, researchers, and the medical community. Utilizing blockchain technology, Nebula Genomics empowers individuals to control their genomic data while receiving compensation for its use. The marketplace aggregates extensive genetic information, which researchers can analyze to enhance drug development and streamline clinical trials, ultimately contributing to personalized medicine. The company's innovative DNA sequencing technology allows for the examination of all genes, regulatory regions, the Y chromosome, and mitochondrial DNA, enabling clients to explore genetic variants comprehensively. Nebula Genomics was co-founded by Harvard genomics pioneer George Church and has received backing from notable investors.

Click Therapeutics, Inc. specializes in the engineering, validation, development, and commercialization of digital therapeutic solutions aimed at addressing unmet medical needs through cognitive and neurobehavioral modification. Founded in 2012 and based in New York, the company offers innovative digital therapeutics for a range of conditions, including smoking cessation, major depressive disorder, schizophrenia, insomnia, and chronic pain. Its Digital Therapeutics™ are designed to function independently or alongside traditional biomedical treatments, utilizing the Clickometrics® adaptive data science platform to personalize user experiences and enhance engagement. Notably, Click's smoking cessation program has gained widespread access through various payers and providers, while its primary prescription program is advancing into a significant phase III clinical trial for major depressive disorder in adults.

Propeller Health is a digital health platform focused on improving the management of chronic respiratory diseases such as asthma and COPD. The company provides a mobile application and sensors that attach to inhalers, enabling users to track their medication usage, triggers, and symptoms. This data is stored securely in a cloud-based infrastructure and facilitates personalized feedback and education for users. The platform also allows users to set medication reminders and alerts, as well as share their health data with physicians and family members. Propeller Health collaborates with various healthcare organizations and has received multiple awards for innovation in the field. Founded by David Van Sickle, Greg Tracy, and Mark Gehring, the company operates from Wisconsin, United States.

Prognos Health is a prominent health tech company specializing in healthcare analytics aimed at improving disease management and treatment decision-making. Its platform, prognosFACTOR, allows users to quickly query billions of lab and health records from over 325 million de-identified patients, significantly reducing the time needed to answer critical healthcare questions. The Prognos Registry serves as the largest source of clinical diagnostics information across more than 30 disease areas, encompassing over 5 billion medical records for 100 million patients. By employing a suite of 500 proprietary clinical algorithms, Prognos facilitates earlier patient identification, enhancing treatment decisions and risk management. The company collaborates with key stakeholders in the healthcare ecosystem, including pharmaceutical manufacturers and payers, providing HIPAA-compliant patient-centric data through the Prognos Marketplace for various applications such as cohort design and health outcomes analysis.

Biolinq Inc. is a San Diego-based company that specializes in developing skin-applied electronic sensors designed to analyze body fluids for health monitoring. Founded in 2012 and originally known as Electrozyme LLC, Biolinq aims to enhance the experience of individuals with diabetes by providing a more affordable and pain-free alternative to conventional continuous glucose monitoring (CGM) systems. The company's platform features minimally invasive electrochemical biosensors capable of measuring multiple analytes, including glucose, ketones, and lactate. This innovative technology not only facilitates easier blood glucose monitoring but also delivers actionable insights into metabolic health, significantly improving the quality of life for patients managing diabetes.

Lemonaid Health focuses on changing the patient experience and improving and optimizing clinical care through the advancements in machine learning and AI. It leverages evidence-based guidelines and the most up-to-date clinical protocols to offer a service direct to consumers for less than typical co-pays. It was founded in 2013 and is headquartered in San Francisco, California.

Lemonaid Health focuses on changing the patient experience and improving and optimizing clinical care through the advancements in machine learning and AI. It leverages evidence-based guidelines and the most up-to-date clinical protocols to offer a service direct to consumers for less than typical co-pays. It was founded in 2013 and is headquartered in San Francisco, California.

Pillo, Inc. designs and develops a digital care management platform that provides health care plans for adults with chronic conditions at home. The company offers Pillo, a robot, which enable people to manage their health; answer health and wellness questions; connect with healthcare professionals; manage vitamins and medication; and store, dispense, and order refills when required. The company’s robot also sends notifications to the user when medications are missed; sees and hears user to keep them healthy and safe; and syncs with wearables and smart home devices. Pillo, Inc. was incorporated in 2015 and is based in New York, New York.

Propeller Health is a digital health platform focused on improving the management of chronic respiratory diseases such as asthma and COPD. The company provides a mobile application and sensors that attach to inhalers, enabling users to track their medication usage, triggers, and symptoms. This data is stored securely in a cloud-based infrastructure and facilitates personalized feedback and education for users. The platform also allows users to set medication reminders and alerts, as well as share their health data with physicians and family members. Propeller Health collaborates with various healthcare organizations and has received multiple awards for innovation in the field. Founded by David Van Sickle, Greg Tracy, and Mark Gehring, the company operates from Wisconsin, United States.

Chrono Therapeutics Inc., a digital transdermal drug delivery company, develops SmartStop, a digital nicotine replacement therapy. Its wearable solution tailors the timing and dose sizes of drugs, preempts predictable peak disease, and addiction symptoms with a device. The company was incorporated in 2003 and is based in Hayward, California.